Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label Placebos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05633459
What this trial is testing

A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
QurAlis Corporation 69
Early research (Phase 1)Study completedNCT00316459
What this trial is testing

Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects

Who this might be right for
HealthyLong QT Syndrome
Wyeth is now a wholly owned subsidiary of Pfizer 64
Testing effectiveness (Phase 2)Study completedNCT05059327
What this trial is testing

Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

Who this might be right for
Tuberous Sclerosis Complex
Noema Pharma AG 61
Testing effectiveness (Phase 2)Study completedNCT03673670
What this trial is testing

Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD

Who this might be right for
COPD
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA 79
Testing effectiveness (Phase 2)Study completedNCT04573322
What this trial is testing

Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects

Who this might be right for
SARS-CoV-2 (Covid19)
Diffusion Pharmaceuticals Inc 25
Early research (Phase 1)Study completedNCT01475981
What this trial is testing

Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects

Who this might be right for
Healthy
Akros Pharma Inc. 70
Large-scale testing (Phase 3)Study completedNCT03261167
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity

Who this might be right for
Spasticity, Post-Stroke
GlaxoSmithKline 124
Early research (Phase 1)Study completedNCT02093819
What this trial is testing

To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 60
Early research (Phase 1)Study completedNCT03489005
What this trial is testing

Effect of BIA 5 1058 on Cardiac Repolarization

Who this might be right for
Cardiovascular DiseasePulmonary Arterial HypertensionHeart Failure
Bial - Portela C S.A. 49
Large-scale testing (Phase 3)Study completedNCT00280566
What this trial is testing

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Who this might be right for
Bipolar ManiaBipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 584
Large-scale testing (Phase 3)Study completedNCT03338816
What this trial is testing

ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)

Who this might be right for
Acute Hepatic PorphyriaAcute Intermittent PorphyriaPorphyria, Acute Intermittent+4 more
Alnylam Pharmaceuticals 94
Large-scale testing (Phase 3)Study completedNCT02611687
What this trial is testing

Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period

Who this might be right for
Narcolepsy With CataplexyNarcolepsy Without Cataplexy
Bioprojet 110
Early research (Phase 1)Study completedNCT01971502
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469

Who this might be right for
Healthy
Boehringer Ingelheim 68
Early research (Phase 1)Study completedNCT02390154
What this trial is testing

Roniciclib Mass Balance Study

Who this might be right for
Neoplasms
Bayer 7
Early research (Phase 1)Study completedNCT02224105
What this trial is testing

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BI 653048 BS H3PO4 Capsule Assessing Endotoxin-induced Inflammatory Response in Healthy Male Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 56
Large-scale testing (Phase 3)Active Not RecruitingNCT06809595
What this trial is testing

Trial of MM120 for Generalized Anxiety Disorder (Panorama)

Who this might be right for
Generalized Anxiety Disorder
Definium Therapeutics US, Inc. 245
Early research (Phase 1)Study completedNCT02119234
What this trial is testing

Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients

Who this might be right for
COPD
Chiesi Farmaceutici S.p.A. 36
Large-scale testing (Phase 3)Ended earlyNCT00397098
What this trial is testing

Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder

Who this might be right for
Anxiety Disorders
Sanofi 257
Early research (Phase 1)Study completedNCT07780604
What this trial is testing

A SINGLE CENTER, 5-PART STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF GAL-101 SALT IN HEALTHY ADULT AND ELDERLY PARTICIPANTS

Who this might be right for
Healthy Adult Participants
Galimedix Therapeutics Inc 92
Early research (Phase 1)Ended earlyNCT02182271
What this trial is testing

Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 8
Next Page